3,024 hedge funds and large institutions have $145B invested in Pfizer in 2023 Q2 according to their latest regulatory filings, with 144 funds opening new positions, 1,371 increasing their positions, 1,247 reducing their positions, and 180 closing their positions.

Holders
3,024
Holders Change
-62
Holders Change %
-2.01%
% of All Funds
47.7%
Holding in Top 10
51
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-36.25%
% of All Funds
0.8%
New
144
Increased
1,371
Reduced
1,247
Closed
180
Calls
$1.71B
Puts
$2.36B
Net Calls
-$644M
Net Calls Change
-$115M
Name Market Value Shares Shares
Change
Shares
Change %
FA
3201
Fortis Advisors
Pennsylvania
-225 Closed
KM
3202
Kalos Management
Georgia
-200 Closed
FCAS
3203
First Command Advisory Services
Texas
-200 Closed
CAM
3204
ClariVest Asset Management
California
-123 Closed
BA
3205
Bellwether Advisors
Nebraska
-121 Closed
BCMIO
3206
Beacon Capital Management Inc (Ohio)
Ohio
-94 Closed
SC
3207
Schubert & Co
Texas
-20 Closed
RAM
3208
Readystate Asset Management
Illinois
SPM
3209
Symmetry Peak Management
Pennsylvania
DAL
3210
Delta Accumulation LLC
California
WA
3211
WestEnd Advisors
North Carolina
FSA
3212
Financial Sense Advisors
California
CCM
3213
CAAS Capital Management
New York
LP
3214
LMR Partners
United Kingdom
HI
3215
HBK Investments
Texas
CMTU
3216
Capital Markets Trading (UK)
United Kingdom
XS
3217
XR Securities
Illinois
LOAMU
3218
Lombard Odier Asset Management (USA)
New York
TA
3219
Teramo Advisors
Florida
CM
3220
Caption Management
Oklahoma
HF
3221
HRT Financial
New York
Walleye Capital
3222
Walleye Capital
New York
PP
3223
Paloma Partners
Connecticut